Bigway Medical was listed among Chinese healthcare and life-sciences companies with a reported RMB 30 million Series B funding round on 12 October. The financing highlights investor interest in medical technology and healthcare innovation.
Healthcare providers and medical technology companies can explore opportunities in diagnostic systems, clinical data analytics and healthcare infrastructure. The RMB 30 million figure is reported startup funding, not a confirmed healthcare service contract.
← Back to Business News